CY2023 Q4
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| SEMPRA | $3,000,000.00 | 2023-11-30 | View |
| CYTODYN INC. | $400,000.00 | 2023-12-31 | View |
| NUTEX HEALTH INC. | $800,000.00 | 2024-01-22 | View |
| Edgewise Therapeutics, Inc. | $600,000.00 | 2024-01-23 | View |
| Ensysce Biosciences, Inc. | $10,200,000.00 | 2023-11-30 | View |
| AUGMEDIX, INC. | $2,500,000.00 | 2023-11-30 | View |
| Momentus Inc. | $400,000.00 | 2024-01-12 | View |
| REVELATION BIOSCIENCES, INC. | $800,000.00 | 2024-02-05 | View |
| SABLE OFFSHORE CORP. | $0.00 | 2024-02-13 | View |
| Longboard Pharmaceuticals, Inc. | $500,000.00 | 2024-01-31 | View |
| ELEVAI LABS INC. | $762,194.00 | 2023-11-21 | View |
| Cycurion, Inc. | $85,000.00 | 2023-12-27 | View |
| SAFE AND GREEN DEVELOPMENT CORPORATION | $1,865,400.00 | 2023-12-31 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations